Tissue-Derived Stem Cell Research 2019View this Special Issue
Research Article | Open Access
Deping Meng, Yuhong Qin, Nan Lu, Keke Fang, Yuan Hu, Zhigang Tian, Cai Zhang, "Kupffer Cells Promote the Differentiation of Adult Liver Hematopoietic Stem and Progenitor Cells into Lymphocytes via ICAM-1 and LFA-1 Interaction", Stem Cells International, vol. 2019, Article ID 4848279, 15 pages, 2019. https://doi.org/10.1155/2019/4848279
Kupffer Cells Promote the Differentiation of Adult Liver Hematopoietic Stem and Progenitor Cells into Lymphocytes via ICAM-1 and LFA-1 Interaction
It has been reported that the adult liver contains hematopoietic stem and progenitor cells (HSPCs), which are associated with long-term hematopoietic reconstitution activity. Hepatic hematopoiesis plays an important role in the generation of cells involved in liver diseases. However, how the progenitors differentiate into functional myeloid cells and lymphocytes in the liver microenvironment remains unknown. In the present study, HSPC transplantation experiments were used to confirm that adult murine liver HSPCs differentiate into both myeloid cells and lymphocytes (preferentially T cells) compared with bone marrow HSPCs. Using a coculture system comprised of kupffer cells and HSPCs, we found that kupffer cells promote adult liver HSPCs to primarily generate T cells and B cells. We then demonstrated that kupffer cells can also promote HSPC expansion. A blockade of intercellular cell adhesion molecule-1 (ICAM-1) in a liver HSPC and kupffer cell coculture system impaired the adhesion, expansion, and differentiation of HSPCs. These results suggest a critical role of kupffer cells in the maintenance and promotion of adult mouse liver hematopoiesis. These findings provide important insight into understanding liver extramedullary hematopoiesis and its significance, particularly under the state of some liver diseases, such as hepatitis, nonalcoholic fatty liver disease (NAFLD), and hepatocellular carcinoma (HCC).
It has been established that the liver is the major hematopoietic organ during fetal period. After birth, hematopoietic stem cells reside primarily in the bone marrow. In adults, extramedullary hematopoiesis occurs in the liver, spleen, and other solid organs when hematopoiesis in the bone marrow fails, as a result of some pathological conditions [1–4]. It has been reported that the adult liver contains Linlo/-sca-1+c-kit+ cells which exhibit colony-forming ability in vitro and reconstruct the multilineage hematopoiesis of lethally irradiated recipient mice in vivo . Later, CD45+ liver side population (SP) cells, isolated based on Hoechst 33342 dye staining, are reported which have the potential of hematopoietic reconstitution and generate the lymphoid, myeloid, and erythroid lineages in the lethally irradiated recipient mice . Moreover, HSPCs were found in the adult human liver, and liver grafts after extensive perfusion can restore the recipient multilineage hematopoiesis to some extent [5–7]. Although hepatic hematopoiesis plays an important role in the generation of cells involved in tumor surveillance and rejection , there is a lack of systemic research comparing the differences between hematopoiesis and lymphogenesis between the adult liver and bone marrow and how the liver microenvironment contributes to these events. The quiescence, proliferation, and differentiation of HSPCs in the bone marrow require a specific niche. Macrophages, endothelial cells, perivascular cells, and other stromal cells play critical roles in maintaining the hematopoietic stem cell pool and regulating HSPC activity by producing a wide variety of cytokines, hematopoietic growth factors, chemokines, and adhesion molecules [9–11]. Among these, adhesion receptors and their ligands (e.g., ICAM-1/LFA-1 and VCAM-1/VLA-4) are important for regulating hematopoietic function and anchoring HSPCs to the niche [12, 13]. Indeed, an ICAM-1 deficiency impairs the quiescence and repopulation activity of HSPCs in the bone marrow niche [13, 14]. However, factors in the adult liver hematopoietic niche for HSPCs remain poorly understood.
In the present study, we detected the presence of heterogeneous Lin-Sca-1+c-Kit+ (LSK, contains hematopoietic stem cells and multipotent progenitors) cells  in the adult murine liver. Through HSPC transplantation experiments, we observed that liver LSK cells differentiate into both myeloid cells and lymphocytes, particularly preferentially generated T cells compared with bone marrow HSPCs. We next explored how the liver microenvironment promotes liver hematopoiesis and lymphocyte differentiation and which factors are required. We found that kupffer cells could induce liver HSPCs to differentiate into a relatively high proportion of T and B lymphocytes in an ICAM-1/LFA-1 interaction-dependent manner.
2. Materials and Methods
2.1. Animal Strains and Treatment Protocol
Six- to eight-week-old male C57BL/6j mice were obtained from Hua Fukang Biological Technology Co. Ltd. (Beijing, China) and maintained in a pathogen-free animal facility. Male and female C57BL/6-Ly5.1 (CD45.1) were obtained from Beijing Vital River Laboratory Animal Technology Co. Ltd. An adult murine liver extramedullary hematopoietic model was established by an intraperitoneal injection of 10 μg/mL LPS for three days. An intravenous injection of clodronate-liposome (CL, Shanghai Yisheng Biological Technology Co. Ltd.) was used to remove the liver kupffer cells . CL was injected to mice on the first and third days. From the second day, C57BL/6j mice were treated with an intraperitoneal injection of 10 μg/mL LPS for three days. The tissue was harvested on the fourth day and tissue mononuclear cells were detected by flow cytometry. All animal protocols were approved by the Institutional Animal Care and Use Committee at Shandong University.
2.2. Colony-Forming Unit Assay
A total of sorted bone marrow or liver LSK cells were suspended in methyl cellulose semisolid medium (1.5% methylcellulose in IMDM) and seeded into a 24-well culture plate to which hematopoietic growth factors (SCF 50 ng/mL, Flt3-L 50 ng/mL, IL-3 20 ng/mL, IL-7 20 ng/mL, M-CSF 50 ng/mL, and GM-CSF 50 ng/mL) were added. The cells were incubated at 37°C in 5% CO2 for 14 days. The number of colonies (with >50 cells) of colony-forming unit-granulo-macrophage (CFU-GM) and CFU-macrophage (CFU-M) was counted under a light microscope on day 14 .
2.3. Flow Cytometry
Bone marrow and liver mononuclear cells were harvested . Single cell suspensions were blocked with an Fc receptor CD16/CD32 at room temperature. After 10 min, the cells were stained with a cocktail of antibodies. For HSC staining, mononuclear cells from the bone marrow and liver were stained with antibodies against the lineage antibodies cocktain-percpcyTM5.5, sca-1-APC, CD117-PE-eFluor610, Flk2-PE, and CD34-FITC cocktail. After 30 min of staining at room temperature, the cells were washed with a 1× phosphate buffer solution (PBS). For the transplantation studies, peripheral blood was obtained by retro-orbital bleeding and red blood cell depletion. Samples were stained for 30 min at room temperature with antibodies against CD45.1-PE-CF594, CD45.2-APC, CD3-PE-cy7, CD19-PE, CD11b-FITC, and NK1.1-APC-cy7. For the coculture studies, samples were stained for 30 min at room temperature with antibodies against CD3-PE-cy7, CD19-APC-cy7, CD11b-PE, and NK1.1-APC. For flow cytometric sorting and LSK cell analysis, liver mononuclear cells were stained with antibodies against lineage antibody cocktain-percpcyTM5.5, sca-1-APC, CD117-PE-eFluor610, LFA-1-PE-cy7, and VLA-4-FITC. Kupffer cells were stained with antibodies against F4/80-PE-CF594, CD11b-PE, ICAM-1-APC, and VCAM-1-FITC. For Ki-67 staining of LSK cells, the samples were stained for 30 min at room temperature with antibodies against lineage antibody cocktain-percpcyTM5.5, sca-1-APC, CD117-PE-eFluor610, and Ki-67-PE. The cells were analyzed and sorted using a FACSAria III cell sorter (BD). The purity of sorting was higher than 95%. The antibodies are presented in Table S1.
2.4. Kupffer Cell Isolation
Kupffer cells were isolated by collagenase digestion and Percoll density gradient centrifugation. The mice were anaesthetized with 2 mg/mL/20 kg lidocaine prior to a laparotomy. The portal vein was cannulated with a 24 G indwelling needle, and the liver was perfused with 1-3 mL EGTA/HBSS solution. The inferior vena cava was rapidly cut off after the liver turned completely pale. Next, the liver was perfused with 37°C prewarmed collagenase solution for 5 min. The liver was then excised and transferred to a culture dish containing a collagenase solution and digested for 15 min in a 37°C incubator. The liver homogenate was then filtered to a 50 mL centrifuge tube. The cell suspension was centrifuged three times at 50 × g for 3 min. The final cell supernatant was centrifuged at 500 × g for 8 min. The cell precipitate was resuspended in 25% Percoll and slowly added to 50% Percoll. The 25%/50% Percoll gradient was centrifuged at 800 × g for 15 min. The interface of the gradient kupffer cell-enriched fraction was resuspended in 1× PBS and centrifuged at 500 × g for 8 min. The cellular precipitate was resuspended in 1 mL DMEM+10% FBS medium. The cells were then seeded into 24-well plates at a density of cells/well. The cells were incubated at 37°C in a 5% CO2 incubator. After 30 min, the medium was gently removed, and the cells were washed three times with 1× PBS, then replaced with 500 μL fresh DMEM medium.
2.5. Real-Time PCR
The total RNA from the liver tissue was extracted using TRIZOL reagent (Invitrogen, Carlsbad, CA, USA). The RNA concentration was quantified using a Nanodrop 2000 (BioTek, Vermont, USA). cDNA was generated using a FastQuant RT Kit (Tiangen Biotech Co. Ltd., Beijing). Real-time polymerase chain reaction (qRT-PCR) was performed using a SYBR Green Supermix (Roche, Basel, Switzerland). The primers are presented in Table S2.
2.6. HSPC Adherence Assay
The HSPC adherence assay was performed according to the method described by Wang et al.  with certain modifications. Liver mononuclear cells were labeled with CFSE for 15 min then washed with 1× PBS. The cell suspensions were Fc blocked with anti-CD16/CD32 at room temperature. After 10 min, the cells were stained with a cocktail of lineage antibody cocktain-percpcy5.5, Sca-1-APC, and CD117-PE-eFluor610 antibodies. Next, CFSE+ LSK cells were sorted by flow cytometry. A density of sorted CFSE+ LSK cells in 500 μL IMDM supplemented with 10% FBS per well was seeded to kupffer cell monolayer (incubated for 1 h in advance with 10 μg/mL anti-ICAM-1 blocking antibodies) in a 24-well plate and incubated at 37°C. After 12 h, the plate was shaken for 30 s on the rocking bed at 120 rpm. Nonadherent CFSE+ cells were removed by pipetting. The cells were gently washed twice and counted by flow cytometry. The ratios of adherent CFSE+ LSK cells to those initially added were calculated.
2.7. Cytokine Detection by ELISA
Freshly isolated kupffer cells ( per well) were seeded into 24-well plates and incubated at 37°C. The culture supernatants were collected at 24 h and 48 h, respectively. The coculture supernatants were collected at 72 h. The level of IL-3, IL-6, SCF, TNF-α, IL-18, and IL-1β in cell culture supernatants was detected using ELISA kits (PeproTech, New Jersey, USA) in accordance with the manufacturers’ instructions.
2.8. HSPC Transplantation
CD45.1 mice were lethally irradiated with a dose of 10 Gy. Mice were fed with water supplemented with 2 mg/mL neomycin. A total of LSK cells obtained from CD45.2 mice were mixed with unfractionated CD45.1+ competitor bone marrow cells and intravenously injected into irradiated CD45.2 recipient mice. Peripheral blood was obtained weekly and the proportion of lymphocytes and myeloid cells was calculated by flow cytometry.
2.9. Immunofluorescence Microscopy
Liver mononuclear cells were harvested and labeled with CFSE. CFSE+ LSK cells were sorted by flow cytometry and injected into mice via the tail vein. The next day, the liver tissue was harvested and soaked in OTC entrapment agent. Frozen sections of the liver tissue were made by first fixing the livers in 4% paraformaldehyde for 15 min. The samples were washed three times with 1× PBS for 5 min. Then, the tissues were incubated in 5% BSA for 30 min at room temperature  before the tissue sections were stained with anti-ICAM-1 and anti-F4/80 antibodies overnight at 4°C. The samples were then washed three times with 1× PBS for 5 min and stained with 7-amino-4-methylcoumarin-3-acetic acid (AMCA) goat anti-mouse IgG (H+L) and Alexa Flour 594 goat anti-rabbit IgG (H+L) at room temperature for 1 h. The samples were washed three times with 1× PBS for 5 min and microscopic images were acquired using a laser confocal microscope (LSM780, Carle Zeiss AG, Germany).
2.10. Statistical Analysis
The data were analyzed using GraphPad Prism 5 software (GraphPad Software Inc. USA). Statistical differences were calculated using a two-tailed Student -test. A threshold value of was considered significant.
3.1. The Adult Murine Liver Contains Hematopoietic Progenitor Cells
Hematopoietic stem cells first appear in the aorta-gonad-mesonephros (AGM) region on embryonic day (E) 10.5, then migrate to the fetal liver around E11.5, where they undergo dramatic expansion [21–26]. Moreover, previous studies have identified the presence of LSK cells in the adult liver . To confirm the presence of hematopoietic progenitor cells in the adult murine liver, we detected and compared the proportion of LSK cells in the livers from mice at different developmental stages by flow cytometry (Figure S1(a) and Figures 1(a)–1(d)). The results showed that there was a higher proportion of LSK cells in the fetal liver around E13.5 (Figures 1(a) and 1(b)) and subsequently decreased gradually from E13.5 to neonatal birth with a frequency of about to Lin- cells (Figure 1(b)). From neonatal birth to adult, a small number of LSK cells remained in the liver, although at lower numbers than that exhibited during the embryo stages. The percentage of LSK cells in the adult liver was approximately of the Lin- cells in the liver (Figure 1(c)), which was lower than that observed in the bone marrow (Figures 1(c) and 1(d)).
To further verify the hematopoietic activity of the LSK cells derived from the adult livers, we first tested the colony-formation activity of the liver mononuclear cells compared with the bone marrow mononuclear cells as a control using a methylcellulose semisolid medium assay. As expected, liver mononuclear cells could form GM-CFU and M-CFU clones (Figure 1(e)). As shown in Figure 1(f), GM-CFU clones and M-CFU clones from the liver mononuclear cells were detected on day 12 of culture. These results indicate that liver mononuclear cells contain hematopoietic progenitor cells and have the ability to form colonies, although this ability was weaker than that derived from the bone marrow. We next detected the colony-formation ability of LSK cells sorted from the liver and bone marrow by flow cytometry. We found that the LSK cells derived from the liver had the ability to form GM-CFU and M-CFU clones (Figure 1(g)); however, the total numbers of GM-CFU and M-CFU clones derived from the liver LSK cells were significantly lower than those isolated from the bone marrow (Figure 1(h)). These findings indicate that liver LSK cells can form hematopoietic clones, albeit to a weaker extent than bone marrow LSK cells. In summary, these results suggest the presence of hematopoietic progenitor cells in the adult murine liver and the hematopoietic potential of liver LSK cells.
3.2. Murine Adult Liver LSK Cells Are Capable of Generating Both Lymphoid and Myeloid Cells In Vivo
As early as 1996, Taniguchi et al. found that LSK cells in the adult liver could reconstruct the multilineage hematopoiesis . However, the proportion of CD3+ T cells and NK1.1+ cells was not detected in prior reports. To confirm the hematopoietic function of LSK cells in the murine adult liver, the repopulating capacity of LSK cells was examined with a competitive repopulating assay. A total of LSK cell suspensions obtained from either the liver or bone marrow of donor CD45.2+ mice was mixed with competitor bone marrow mononuclear cell suspensions from CD45.1 mice and injected into lethally irradiated CD45.1+ recipients to confirm the hematopoietic-reconstitution activity (Figure S1(a) and 1(b)). Donor-derived (CD45.2+) CD3+, CD19+, NK1.1+, and CD11b+ cells were detected in the peripheral blood of CD45.1+ recipient mice at different time points following transplantation. As shown in Figures 2(a)–2(f), the LSK cells derived from the liver can give rise to a high proportion of lymphocytes (including T and B cells) from three weeks following transplantation; however, the hematopoietic reconstitution ability of the LSK cells derived from the liver is significantly weaker than that isolated from the bone marrow. We found that LSK cells from the liver preferentially differentiate into T cells compared with those from the bone marrow. Moreover, LSK cells derived from the bone marrow mainly produced B cells and generated fewer T cells. There were no differences observed regarding the repopulation of NK and myeloid cells between the liver- and bone marrow-derived LSK cells (Figures 2(a)–2(f)). To determine the destination and sites of differentiation of liver LSK cells after transplantation, we detected CD45.2+ cells in the recipient liver and BM after LSK transplantation at the ninth week. The results showed that CD45.2+ cells can be detected in the liver but not in the BM in mice receiving liver LSK transplantation (Figure 2(g)). Similar with those in the peripheral blood (Figure 2(e)), differentiated CD3+ T cells, CD19+ B cells, NK1.1+ T cells, and CD11b+ myeloid cells, especially CD3+ T cells, from CD45.2+ donor cells were detected in the liver (Figure 2(g)). However, for BM LSK transplantation, CD45.2+ cells were detected in both recipient BM and liver; CD45.2+ donor-derived CD3+ T cells, CD19+ B cells, NK1.1+ T cells, and CD11b+ myeloid cells were generated in the liver, among which CD19+ B cells were dominant (Figure 2(g)). These results suggested that liver-derived LSK cells specifically home to the liver, where they further differentiate into lymphocytes and myeloid cells, but rarely return to the BM. However, BM-derived LSK cells can move to both the BM and liver. Taken together, these results indicated that adult liver HSPCs can destine to the liver where they differentiate into both lymphoid and myeloid cells, particularly with the preferential T cell differentiation.
3.3. Kupffer Cells Promote LPS-Induced Liver Hematopoiesis
Next, we explored whether the adult liver, like the hematopoietic niche in the bone marrow, contains factors that regulate the retention, proliferation, quiescence, and differentiation of HSPCs. Multiple cellular and molecular components are involved in the maintenance of the bone marrow HSC niche. In particular, it has been reported that macrophages contribute to HSPC maintenance in the bone marrow by CXCL12-CXCR4 chemokine signaling [10, 27–31]. Thus, we investigated whether kupffer cells, as the important resident macrophages of the liver, participate in the maintenance and promotion of the HSPC niche in the liver and the associated mechanism. Since there is only a small number of hematopoietic stem cells located in the normal adult liver during a quiescent state, we used a LPS-stimulated murine extramedullary hematopoiesis model  to promote adult liver hematopoiesis. We detected the frequency of liver LSK cells following an intraperitoneal injection of LPS (Figure S2). Firstly, we measured the number of the LSK cells and long-term hematopoietic stem cells (LT-HSC, Lin-Sca-1+ckit+ Flk2-CD34-) from the bone marrow and liver by flow cytometry. The unstimulated mouse liver contained only a few LSK (approximately of Lin- cells) and LT-HSC (approximately of LSK cells) cells. However, the absolute numbers of liver LSK and LT-HSC cells were dramatically increased in LPS-treated mice compared with unstimulated mice (LSK: from increased to ; LT-HSC: from increased to 0.046 × 104 ± 0.049 × 104) (Figures 3(a) and 3(c)). Similar to the liver, bone marrow LSK cells and LT-HSCs in LPS-treated mice also increased (Figures 3(b) and 3(d)). These results suggest that LPS stimulation promotes extramedullary liver hematopoiesis, similar to the effect on spleen hematopoiesis .
To investigate the contribution of kupffer cells in the process of liver extramedullary hematopoiesis, we intravenously injected CL into LPS-treated mice to delete macrophages and kupffer cells (Figure S2). We first observed that the treatment with CL alone did not affect the distribution of HSPCs in the BM, liver, and spleen (Figure 3(e)). As shown in Figure S3, treatment with CL significantly reduced the proportion of kupffer cells (CD11b+ F4/80+) in the liver, and the percentage of hepatic LSK cells in LPS-treated mice was also significantly reduced (Figures 3(f) and 3(g)). Based on the above data, we propose that the kupffer cells may contribute to LPS-induced liver hematopoiesis.
3.4. Kupffer Cells Sustain Liver HSPCs to Differentiate into T and B Cells In Vitro
To explore how kupffer cells contribute to liver hematopoiesis, we assessed the level of hematopoietic growth factors (SCF, IL-6, and IL-3)  secreted by kupffer cells by culturing freshly isolated kupffer cells for 24 h and 48 h in vitro. As shown in Figure 4(a), certain levels of SCF, IL-6, and IL-3 can be detected in the supernatants of cultured kupffer cells, suggesting that kupffer cells constitutively express these three hematopoietic growth factors.
Next, we evaluated whether kupffer cells could support the proliferation and differentiation of liver HSPCs. We cocultured liver LSK cells and freshly isolated kupffer cells in the presence of SCF with or without 1 μg/mL LPS for 14 days and examined the proportion of differentiated lymphoid and myeloid cells at various time points. On the seventh day, a low percentage of CD3+ T, CD19+ B, NK1.1+, and CD11b+ cells was detected in the coculture system (data not shown). On day 14, we observed that liver LSK cells cultured only with medium and SCF were unable to differentiate into lymphoid and myeloid cells. While the presence of kupffer cells increased the proportion of differentiated CD3+ T, CD19+ B cells in total cells of coculture system compared with the control group and adding LPS in the system enhanced this effect of kupffer cells (Figures 4(b) and 4(c)). To further study which factors promote the differentiation of liver HSPC after LPS stimulation, we assessed the level of proinflammatory factors in the coculture supernatants after LPS stimulation by ELISA. We found that LPS stimulation increased the levels of IL-6, TNF-α, and IL-1β in the coculture system (Figure 4(d)), while other cytokines such as IL-18 showed no significant difference. These results suggest that kupffer cells sustain the differentiation of liver LSK cells in vitro and LPS can promote this effect, during which some cytokines, such as IL-6, may play some regulatory role.
3.5. Kupffer Cells Promote the Proliferation of Liver HSPCs
We further investigated the effect of kupffer cells on the proliferation of hepatic HSPCs. Kupffer cells were stimulated with 1 μg/mL LPS for 6 h, after which the LSK cells were added to the kupffer cell monolayers and cocultured for 24 h. The proportion of LSK cells was measured (Figure 5(a)) and the results showed that the proportion and number of LSK cells significantly increased after coculturing with LPS-stimulated kupffer cells (Figure 5(b)). To explore how LPS-stimulated kupffer cells increased the proliferation of LSK cells, we assessed the proliferative capacity of LSK cells by detecting the expression of ki-67. First, we observed the proportion of ki-67+ LSK cells in the liver following an intraperitoneal injection of LPS and characterized the influence of kupffer cell depletion in vivo (Figure S2). We found that LPS stimulation augmented the percentage of hepatic ki-67+ LSK cells compared with the PBS-treated group (Figures 5(c) and 5(e)), while the removal of kupffer cells significantly reduced the proportion of hepatic ki-67+ LSK cells (Figures 5(c) and 5(e)). Similar results were observed in the bone marrow (Figures 5(d) and 5(f)). The above results indicate that kupffer cells indeed contribute to LPS-induced proliferation of HSPCs in the liver hematopoietic niche.
3.6. Kupffer Cells Promote LPS-Induced Liver Hematopoiesis and Lymphocyte Differentiation via ICAM-1 and LFA-1 Interaction
The above results confirm that kupffer cells could promote the proliferation and differentiation of liver LSK cells. We next aimed to explore whether kupffer cells influence the maintenance of LSK cells in the liver. We measured the level of CXCL12, vascular cell adhesion molecule-1 (VCAM-1), intercellular cell adhesion molecule-1 (ICAM-1), c-kit ligand, and angiopoietin-1 expression in the liver, as these factors have been reported to be involved in the retention of HSPCs in the bone marrow niche [27, 29, 33–35]. We first detected the level of mRNA expression of these factors in the liver tissues isolated from the mouse model described in Figure S2. As shown in Figure S4(a), LPS stimulation markedly enhanced the levels of ICAM-1, VCAM-1, and CXCL12 mRNA in the whole liver tissues but did not influence the levels of c-kit ligand and angiopoietin-1. Depletion of kupffer cells significantly reduced the levels of ICAM-1 and VCAM-1 mRNA, but not CXCL12. We suspect that VCAM-1, ICAM-1, and CXCL12 expression on kupffer cells might contribute to the retention of HSPCs associated with LPS-induced liver extramedullary hematopoiesis. Therefore, we detected the level of CXCL12 in the liver tissue homogenates with an ELISA. We found that the changes in CXCL12 production were not statistically significant following kupffer cell depletion (Figure S4(b)). We then isolated kupffer cells and detected the changes in ICAM-1 and VCAM-1 expression by flow cytometry. Following LPS treatment, while the expression of ICAM-1 increased significantly, the expression of VCAM-1 did not change (Figure 6(a)). We further examined the expression of LFA-1 and VLA-4, which are the corresponding ligands for ICAM-1 and VCAM-1, respectively, on LSK cells. As shown in Figure 6(b), the expression of LFA-1, but not VLA-1, was substantially elevated following LPS treatment. According to these results, we speculate that the interaction between ICAM-1 and LFA-1 plays a major role in kupffer cell maintenance of HSPCs in the liver.
Next, we further tested whether liver LSKs reside closely to ICAM-1-expressing kupffer cells in the anatomical structure of the liver. For this assay, liver LSKs were sorted from CD45.2+ mice by flow cytometry, labelled with CFSE, and then intravenously transferred into CD45.1+ mice. Liver tissue sections were created after one day, and the location of LSK cells was observed using an immunofluorescence assay. We found that CFSE-labeled LSK cells were localized near ICAM-1+ kupffer cells in the liver (Figure 6(c)). To confirm the interaction between ICAM-1 and LFA-1, an adherent assay was performed. Freshly isolated kupffer cells were preincubated with an anti-ICAM-1 Ab (10 μg/mL) and then cocultured with freshly sorted LSK cells. Nonadherent cells were counted after 12 h. We found that the level of adhesion between the LSK and kupffer cells decreased significantly after blocking ICAM-1 (Figure 6(d)). These results suggest that kupffer cells may retain small amounts of LSK cells in the hepatic sinusoid through the interaction between ICAM-1 and LFA-1.
We further examined the effect of kupffer cells on hematopoietic stem cells after blocking ICAM-1 in a coculture system. The liver Lin- cells were sorted and cocultured with kupffer cells in the presence of SCF with or without an anti-ICAM-1 antibody for seven days, and the number of LSK cells was subsequently detected (Figure S4(c)). We found that the total number of LSK cells and Lin- cells significantly declined following the ICAM-1 blockade (Figures 6(e) and 6(f)). We further analyzed the effect of kupffer cells on the differentiation of hematopoietic stem cells. Liver LSK cells were purified and cocultured with kupffer cells for 14 days, and then, the differentiated lymphoid and myeloid cells were detected. We observed that the total number of CD3+ T cells and CD19+ B cells declined when the anti-ICAM-1 treatment group was compared with the control group (Figure 6(g)). Taken together, these phenomena suggest that ICAM-1/LFA-1 plays a major role in the maintenance and differentiation of hepatic HPSCs by mediating close contact between kupffer cells and HSPCs.
Previous reports have indicated that the adult liver contains HSPCs which possess hematopoietic-reconstitution ability [3–6]. However, no studies have comprehensively compared the differences in hematopoiesis and lymphogenesis between the adult liver and bone marrow. Moreover, the key factors in the adult liver microenvironment that contribute to liver hematopoiesis remain unclear. In this study, we confirmed that adult murine liver HSPCs differentiate into lymphoid and myeloid cells. Notably, the ability of liver LSK cells to generate T cells was significantly stronger than that of BM-LSK cells, whereas the BM-derived LSK cells primarily produced B cells. These findings suggest that liver hematopoiesis exhibits features that differ from bone marrow hematopoiesis. Furthermore, we confirmed that the liver resident macrophages, kupffer cells, can promote liver HSPCs to generate a high proportion of T and B lymphocytes through an interaction between ICAM-1 and LFA-1. Blocking ICAM-1 on kupffer cells impaired the adhesion, expansion, and differentiation of adult liver HSPCs. Our findings suggest a critical role of kupffer cells in the maintenance and promotion of adult mouse liver hematopoiesis, particularly T and B cell differentiation in the liver.
The hematopoietic microenvironment, particularly the stem cell niche, is critical for supporting the self-renewal, expansion, and differentiation of HSPCs in hemopoietic tissues . In addition to the required growth factors (e.g., stem cell factors, flt3 ligand, IL- 6, and IL-3), direct interactions between HSPCs and cellular components (e.g., blood vessel endothelial cells, osteoblasts, and mesenchymal stem cells) within the stem cell niche are crucial for the regulation of hematopoiesis [11, 37, 38]. Although the cellular basis of the hematopoietic niche is clear in the bone marrow, the constituents and mechanism of the adult liver hematopoietic niche remain unclarified. Cardier and Barbera-Guillem reported that liver sinusoidal endothelial cells (LSECs) play a key role in supporting the proliferation and differentiation of HSPCs . Moreover, evidence indicates that LSECs provide the signals required for the migration and homing of extramedullary hematopoietic stem cells and promote B lymphopoiesis [40, 41]. However, the role of kupffer cells in liver hematopoiesis has not been fully clarified. Otsuka et al. reported that kupffer cells act as stromal cells and support extramedullary erythropoiesis in the livers of splenectomized mice . Moreover, in a phenylhydrazine-induced extramedullary hematopoiesis model, F4/80+ macrophages were found to be tightly surrounded by erythroblasts in the liver sinusoids, similar to erythropoiesis in the fetal liver . However, the effects and molecular mechanism of kupffer cells on lymphocytopoiesis are poorly understood. In the present study, we found that kupffer cells promote liver hematopoiesis. Our data demonstrates that kupffer cells both contribute to supporting the proliferation of liver HSPCs and sustain liver HSPCs, which differentiate into lymphocytes. Regarding the associated mechanism, we propose that (1) under steady-state conditions, kupffer cells secrete the hematopoietic-promoting factors IL-3, IL-6, and SCF, which support the maintenance of HSPCs and (2) kupffer cells promote liver hematopoiesis and lymphogenesis via an ICAM-1 and LFA-1 interaction. To our knowledge, this is the first report to investigate the role and mechanisms of kupffer cells in the promotion of lymphogenesis during liver extramedullary hematopoiesis. Our data also provides evidence that kupffer cells are an important component of the liver hematopoietic niche.
Although some evidence suggests that there may be different characteristics between liver and bone marrow hematopoiesis, there is a lack of comprehensive comparative studies. Golden-Mason et al.  have reported that the normal adult human liver is capable of supporting T cell development. They found that the normal adult human liver contains a considerable proportion of HSCs expressing lymphoid-associated markers, whereas the majority of CD34+ cells in the bone marrow express the myeloid-associated antigen, CD33, and B cell marker, CD19+, but exhibit fewer T cell progenitors . Based on the findings of a previous study , the present study compared the hematopoietic and lymphopoietic capacity between bone marrow- and liver-derived HSPCs using both an in vivo model and an in vitro coculture. We observed that liver-derived LSK cells specifically home to the liver, where they further differentiate into lymphocytes and myeloid cells, then enter into the peripheral circulation. However, BM-derived LSK cells can move to both the BM and liver. It is notable that liver LSK cells preferentially differentiate into T cells, whereas LSK cells derived from the bone marrow mainly produced B cells and generated fewer T cells. There are no differences regarding the repopulation of NK and myeloid cells between the liver- and bone marrow-derived LSK cells. These findings are consistent with previous reported evidence regarding the supportive role of the human liver in T cell development . Extrathymic T cell differentiation in the liver has also been observed in tumor-bearing mice and patients with tumors or undergoing a liver transplantation [8, 45–47]. It is suggested that T cells of extrathymic origin may be involved in tumor immunity and contribute to immune tolerance following organ transplantation [7, 48, 49]. We also found that LPS could help kupffer cells to promote the differentiation of liver HSPCs into T and B cells. Recent studies have highlighted the important role of LPS production in the pathogenesis of liver diseases, such as NAFLD/NASH and hepatocellular carcinoma (HCC) . Our results may help to study liver hematopoiesis under the state of these liver diseases.
However, the origin of liver HSPCs and the function of T cells derived from the liver HSPCs are still unclear. Next, we need to further confirm whether adult liver HSPCs are derived from a remnant of fetal HSPCs or from bone marrow-circulating HSPCs. It is also necessary to illuminate the function and significance of liver extramedullary hematopoiesis, particularly regarding therapy for liver tumors and related diseases.
In summary, the findings of the present study demonstrate that adult murine liver HSPCs exhibit hematopoietic activity, primarily differentiating into T and B lymphocytes. We further confirmed that kupffer cells can promote the adhesion, proliferation, and differentiation of adult liver HSPCs by the interaction between ICAM-1 and LFA-1. These findings provide important insight into understanding the liver hematopoietic microenvironment and may aid in the development of novel therapies for liver-related diseases and the maintenance of immune tolerance following liver transplantation.
The data used to support the findings of this study are included within the article.
The abstract of this manuscript has been presented as a conference abstract in “The 13th National Immunology Academic Conference Sub-meeting Exchange Report” held by the Chinese Society for Immunology .
Conflicts of Interest
The authors declare that they have no competing interests.
C.Z. directed the research program, provided guidance and suggestions for the experimental design, analyzed the data, and wrote the manuscript. D.M. performed and designed the experiments, analyzed the data, and wrote the manuscript. Y.Q. and K.F. performed the experiments. N.L. provided guidance for the experiment design and contributed to analyzing and discussing the data. Z.T. provided guidance and suggestions for the study.
This work was supported by the following grants to C.Z.: the National Natural Science Foundation of China (91842305, 91442114, and 81771686), the National 973 Basic Research Program of China (2013CB944901), and the National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases in China (2018ZX10301401).
Supplementary Table S1: mouse antibody list. Supplementary Table S2: primer sequences used for real-time PCR. Supplementary Figure S1: analysis and sorting strategy of the bone marrow, liver, and fetal liver LSK cells. Supplementary Figure S2: flow chart of kupffer cell depletion and LPS treatment. Supplementary Figure S3: clodronate-liposome treatment significantly reduced the proportion of kupffer cells in the liver. Supplementary Figure S4: factors promoting and maintaining liver hematopoiesis. (Supplementary Materials)
- P. Dutta, F. F. Hoyer, L. S. Grigoryeva et al., “Macrophages retain hematopoietic stem cells in the spleen via VCAM-1,” The Journal of Experimental Medicine, vol. 212, no. 4, pp. 497–512, 2015.
- E. Lefrançais, G. Ortiz-Muñoz, A. Caudrillier et al., “The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors,” Nature, vol. 544, no. 7648, pp. 105–109, 2017.
- H. Taniguchi, T. Toyoshima, K. Fukao, and H. Nakauchi, “Presence of hematopoietic stem cells in the adult liver,” Nature Medicine, vol. 2, no. 2, pp. 198–203, 1996.
- D. N. Kotton, A. J. Fabian, and R. C. Mulligan, “A novel stem-cell population in adult liver with potent hematopoietic-reconstitution activity,” Blood, vol. 106, no. 5, pp. 1574–1580, 2005.
- T. Sakamoto, N. Murase, Q. Ye, T. E. Starzl, and A. J. Demetris, “Identification of donor hematopoietic progenitor cells after allogeneic liver transplantation,” Transplantation Proceedings, vol. 29, no. 1-2, p. 1211, 1997.
- R. H. Collins Jr., J. Anastasi, L. Terstappen et al., “Donor-Derived Long-Term Multilineage Hematopoiesis in a Liver-Transplant Recipient,” The New England Journal of Medicine, vol. 328, no. 11, pp. 762–765, 1993.
- X. Q. Wang, C. M. Lo, L. Chen et al., “Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver,” Hepatology, vol. 56, no. 4, pp. 1557–1566, 2012.
- L. Golden-Mason, M. P. Curry, N. Nolan et al., “Differential expression of lymphoid and myeloid markers on differentiating hematopoietic stem cells in normal and tumor-bearing adult human liver,” Hepatology, vol. 31, no. 6, pp. 1251–1256, 2000.
- A. Mendelson and P. S. Frenette, “Hematopoietic stem cell niche maintenance during homeostasis and regeneration,” Nature Medicine, vol. 20, no. 8, pp. 833–846, 2014.
- A. Chow, D. Lucas, A. Hidalgo et al., “Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche,” The Journal of Experimental Medicine, vol. 208, no. 2, pp. 261–271, 2011.
- L. Ding, T. L. Saunders, G. Enikolopov, and S. J. Morrison, “Endothelial and perivascular cells maintain haematopoietic stem cells,” Nature, vol. 481, no. 7382, pp. 457–462, 2012.
- A. Ghobadi, M. P. Rettig, M. L. Cooper et al., “Bortezomib is a rapid mobilizer of hematopoietic stem cells in mice via modulation of the VCAM-1/VLA-4 axis,” Blood, vol. 124, no. 17, pp. 2752–2754, 2014.
- Y. F. Liu, S. Y. Zhang, Y. Y. Chen et al., “ICAM-1 deficiency in the bone marrow niche impairs quiescence and repopulation of hematopoietic stem cells,” Stem Cell Reports, vol. 11, no. 1, pp. 258–273, 2018.
- S. Chen, M. Lewallen, and T. Xie, “Adhesion in the stem cell niche: biological roles and regulation,” Development, vol. 140, no. 2, pp. 255–265, 2013.
- K. Chotinantakul and W. Leeanansaksiri, “Hematopoietic stem cell development, niches, and signaling pathways,” Bone Marrow Research, vol. 2012, Article ID 270425, 16 pages, 2012.
- C. Zhang, J. Feng, J. du et al., “Macrophage-derived IL-1α promotes sterile inflammation in a mouse model of acetaminophen hepatotoxicity,” Cellular & Molecular Immunology, vol. 15, no. 11, pp. 973–982, 2018.
- D. M. Tian, Y. M. Liang, and Y. Q. Zhang, “Endothelium-targeted human Delta-like 1 enhances the regeneration and homing of human cord blood stem and progenitor cells,” Journal of Translational Medicine, vol. 14, no. 1, 2016.
- C. Zheng, S. Yin, Y. Yang, Y. Yu, and X. Xie, “CD24 aggravates acute liver injury in autoimmune hepatitis by promoting IFN-γ production by CD4+ T cells,” Cellular & Molecular Immunology, vol. 15, no. 3, pp. 260–271, 2018.
- W. Wang, S. Yu, G. Zimmerman et al., “Notch receptor-ligand engagement maintains hematopoietic stem cell quiescence and niche retention,” Stem Cells, vol. 33, no. 7, pp. 2280–2293, 2015.
- H. Zhang, R. Xue, S. Zhu et al., “M2-specific reduction of CD1d switches NKT cell-mediated immune responses and triggers metaflammation in adipose tissue,” Cellular & Molecular Immunology, vol. 15, no. 5, pp. 506–517, 2018.
- A. M. Müller, A. Medvinsky, J. Strouboulis, F. Grosveld, and E. Dzierzakt, “Development of hematopoietic stem cell activity in the mouse embryo,” Immunity, vol. 1, no. 4, pp. 291–301, 1994.
- A. Medvinsky and E. Dzierzak, “Definitive hematopoiesis is autonomously initiated by the AGM region,” Cell, vol. 86, no. 6, pp. 897–906, 1996.
- J. L. Christensen, D. E. Wright, A. J. Wagers, and I. L. Weissman, “Circulation and chemotaxis of fetal hematopoietic stem cells,” PLoS Biology, vol. 2, no. 3, 2004.
- S. Taoudi and A. Medvinsky, “Functional identification of the hematopoietic stem cell niche in the ventral domain of the embryonic dorsal aorta,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 22, pp. 9399–9403, 2007.
- C. Souilhol, J. G. Lendinez, S. Rybtsov et al., “Developing HSCs become Notch independent by the end of maturation in the AGM region,” Blood, vol. 128, no. 12, pp. 1567–1577, 2016.
- Y. Qin and C. Zhang, “The Regulatory Role of IFN-γ on the Proliferation and Differentiation of Hematopoietic Stem and Progenitor Cells,” Stem Cell Reviews, vol. 13, no. 6, pp. 705–712, 2017.
- A. Avigdor, P. Goichberg, S. Shivtiel et al., “CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow,” Blood, vol. 103, no. 8, pp. 2981–2989, 2004.
- T. Sugiyama, H. Kohara, M. Noda, and T. Nagasawa, “Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches,” Immunity, vol. 25, no. 6, pp. 977–988, 2006.
- A. Greenbaum, Y. M. S. Hsu, R. B. Day et al., “CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance,” Nature, vol. 495, no. 7440, pp. 227–230, 2013.
- R. Janssens, S. Struyf, and P. Proost, “The unique structural and functional features of CXCL12,” Cellular & Molecular Immunology, vol. 15, no. 4, pp. 299–311, 2018.
- I. G. Winkler, N. A. Sims, A. R. Pettit et al., “Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs,” Blood, vol. 116, no. 23, pp. 4815–4828, 2010.
- Q. Chen, “The niche for hematopoietic stem cell expansion: a collaboration network,” Cellular & Molecular Immunology, vol. 14, no. 10, pp. 865–867, 2017.
- H. A. Crosby, P. F. Lalor, E. Ross, P. N. Newsome, and D. H. Adams, “Adhesion of human haematopoietic (CD34+) stem cells to human liver compartments is integrin and CD44 dependent and modulated by CXCR3 and CXCR4,” Journal of Hepatology, vol. 51, no. 4, pp. 734–749, 2009.
- H. Bonig and T. Papayannopoulou, “Hematopoietic stem cell mobilization: updated conceptual renditions,” Leukemia, vol. 27, no. 1, pp. 24–31, 2013.
- V. W. C. Yu and D. T. Scadden, “Hematopoietic stem cell and its bone marrow niche,” Current Topics in Developmental Biology, vol. 118, pp. 21–44, 2016.
- G. M. Crane, E. Jeffery, and S. J. Morrison, “Adult haematopoietic stem cell niches,” Nature Reviews Immunology, vol. 17, no. 9, pp. 573–590, 2017.
- S. Méndez-Ferrer, T. V. Michurina, F. Ferraro et al., “Mesenchymal and haematopoietic stem cells form a unique bone marrow niche,” Nature, vol. 466, no. 7308, pp. 829–834, 2010.
- K. O’Hagan-Wong, S. Nadeau, A. Carrier-Leclerc et al., “Increased IL-6 secretion by aged human mesenchymal stromal cells disrupts hematopoietic stem and progenitor cells’ homeostasis,” Oncotarget, vol. 7, no. 12, pp. 13285–13296, 2016.
- J. E. Cardier and E. Barbera-Guillem, “Extramedullary hematopoiesis in the adult mouse liver is associated with specific hepatic sinusoidal endothelial cells,” Hepatology, vol. 26, no. 1, pp. 165–175, 1997.
- O. Wittig, J. Paez-Cortez, and J. E. Cardier, “Liver sinusoidal endothelial cells promote B lymphopoiesis from primitive hematopoietic cells,” Stem Cells and Development, vol. 19, no. 3, pp. 341–350, 2010.
- M. Mendt and J. E. Cardier, “Stromal-derived factor-1 and its receptor, CXCR4, are constitutively expressed by mouse liver sinusoidal endothelial cells: implications for the regulation of hematopoietic cell migration to the liver during extramedullary hematopoiesis,” Stem Cells and Development, vol. 21, no. 12, pp. 2142–2151, 2012.
- H. Otsuka, H. Yagi, Y. Endo, N. Nonaka, and M. Nakamura, “Kupffer cells support extramedullary erythropoiesis induced by nitrogen-containing bisphosphonate in splenectomized mice,” Cellular Immunology, vol. 271, no. 1, pp. 197–204, 2011.
- Y. Sonoda and K. Sasaki, “Hepatic extramedullary hematopoiesis and macrophages in the adult mouse: histometrical and immunohistochemical studies,” Cells Tissues Organs, vol. 196, no. 6, pp. 555–564, 2012.
- X. Jiang, Y. Chen, H. Wei, R. Sun, and Z. Tian, “Characterizing the lymphopoietic kinetics and features of hematopoietic progenitors contained in the adult murine liver in vivo,” PLoS One, vol. 8, no. 10, 2013.
- G. A. Bishop and G. W. McCaughan, “Immune activation is required for the induction of liver allograft tolerance: implications for immunosuppressive therapy,” Liver Transplantation, vol. 7, no. 3, pp. 161–172, 2001.
- J. A. Pons Minano, P. Ramirez Romero, R. Robles Campos, F. Sanchez Bueno, and P. Parrilla Paricio, “Tolerance and chimerism in liver transplantation,” Revista Espanola de Enfermedades Digestivas, vol. 99, no. 6, pp. 343–350, 2007.
- G. A. Bishop, C. Wang, A. F. Sharland, and G. W. McCaughan, “Spontaneous acceptance of liver transplants in rodents: evidence that liver leucocytes induce recipient T-cell death by neglect,” Immunology and Cell Biology, vol. 80, no. 1, pp. 93–100, 2002.
- X. Shi, V. Moroso, H. J. Metselaar, and J. Kwekkeboom, “Long-lived intragraft donor leukocytes or relocated donor hematopoietic stem/progenitor cells can cause long-term hematopoietic chimerism after liver transplantation,” Hepatology, vol. 57, no. 6, p. 2542, 2013.
- M. W. Robinson, C. Harmon, and C. O’Farrelly, “Liver immunology and its role in inflammation and homeostasis,” Cellular & Molecular Immunology, vol. 13, no. 3, pp. 267–276, 2016.
- J. Boursier and A. M. Diehl, “Implication of gut microbiota in nonalcoholic fatty liver disease,” PLoS Pathogens, vol. 11, no. 1, 2015.
- D. Meng, Y. Qin, N. Lu, K. Fang, Z. Tian, and C. Zhang, “Kupffer cells promote the differentiation of adult liver hematopoietic stem and progenitor cells into lymphocytes via ICAM-1 and LFA-1 interaction,” in 13Th Annual Meeting of Chinese Society for Immunology, p. 107, Shanghai, China, 2018, 1994-2019 China Academic Journal Electronic Publishing House.
Copyright © 2019 Deping Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.